Michelle Monje, MD, PhD, is an Associate Professor of Neurology and, by courtesy, of Neurosurgery, Psychiatry, Pathology and Pediatrics. Dr. Monje received her M.D. and Ph.D. in Neuroscience from Stanford University. As a Ph.D. student under the mentorship of Dr. Theo Palmer, Dr. Monje studied microenvironmental determinants of neural stem cell fate choice. Dr. Monje completed her residency training in neurology at the Massachusetts General Hospital/Brigham and Women’s Hospital/Harvard Medical School Partners program, and then returned to Stanford for a clinical fellowship in pediatric neuro-oncology and a post-doctoral fellowship with Dr. Philip Beachy. During her postdoctoral work, Dr. Monje focused on the neurodevelopmental origins of a devastating pediatric brain tumor called diffuse intrinsic pontine glioma (DIPG). Dr. Monje’s research program studies the molecular and cellular mechanisms of postnatal neurodevelopment and pediatric gliomagenesis. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states. Areas of emphasis include neuron-glial interactions, developmental and adaptive myelination, and microenvironmental contributions to glioma pathogenesis. As a practicing neurologist and neuro-oncologist, Dr. Monje is particularly interested in the identifying novel therapeutic strategies for pediatric gliomas, the neural regulation of cancer progression and the neurological consequences of cancer treatment.